We are monitoring the impact of COVID-19 on Latin America Hemophilia Management Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 274
Share on
Share on

Latin America Hemophilia Management Market Research Report – Segmented By Type, Drug & By Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) – Analysis on Size, Share, Trends, Growth, Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 274
Pages: 137

Latin America Hemophilia Management Market Size & Growth (2021 to 2026)

As per the report, the size of the Latin America Hemophilia Management Market was worth USD 650.82 million in 2021 and estimated to be growing at a CAGR of 1.69%, to reach USD 707.70 million by 2026.

Hemophilia is a genetic disorder that impairs the body`s ability to control blood clotting. Hemophilia usually occurs in males and it is estimated that about 1 in 5000 males that are born each year contain hemophilia.

Hemophilia is categorized into three levels depending on its severity as severe, moderate and mild. About 80% of the hemophilia patients are considered to suffer from severe type. It is estimated that around 75% of the patients suffering from hemophilia do not receive adequate treatment.

Latin America Hemophilia market is driven by factors such as the growing prevalence of the disease and the increasing usage of recombinant products. Advancements in technology have brought novel regulating factors that are also helping in the growth of the market. Rising investments into Research and developments are also a major factor supporting the market growth.

However, lack of awareness of the disease and high costs associated with the treatment of the disease are the major factors hindering the market growth. Advancements in gene therapy and approaching approval of drugs for the treatment of hemophilia provide immense growth opportunities in the market.

This research report on the Latin America Hemophilia Management Market is segmented and sub-segmented into the following categories:

By Type:

  • Hemophilia A
  • Hemophilia B

By Drug:

  • Octocogalfa
  • Nonacogalfa
  • Desmopressin
  • Other Drugs

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, the Latin America region provides lucrative growth opportunities for the hemophilia management market attributed to local government support and the increasing focus of global players towards these countries. Within Latin America, Argentina is a major market accounting for a significant share within the region due to more open investment prospects

Few of the key companies dominating the LATAM Hemophilia Management Market profiled in this report are Biogen, Baxter International Inc., Pfizer Inc., Bayer Pharma AG, Novo Nordisk A/S, Grifols International SA, CSL Behring, Octapharma and Swedish Orphan Biovitrum AB

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 BY Type                                        

                                5.1.1 Hemophilia A                         

                                5.1.2 Hemophilia B                          

                5.2 By Drug                                        

                                5.2.1 Octocogalfa                            

                                5.2.2 Nonacogalfa                           

                                5.2.3 Desmopressin                       

                                5.2.4 Other drugs                            

  1. Geographical Analysis

                                6.1 Introduction                               

                                6.2 Brazil                             

                                6.3 Mexico                         

                                6.4 Argentina                    

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 Biogen                                          

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Baxter International Inc.                                       

                8.4 Bayer Pharma AG                                    

                8.5 Novo Nordisk A/S                                    

                8.6 Grifols International SA                                         

                8.7 CSL Behring                                

                8.8 Octapharma                                               

                8.9 Swedish Orphan Biovitrum AB                                           

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

    Appendix                                                          

a) List of Tables

b) List of Figures

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Hemophilia Management Market By Region, From 2021 to 2026 (USD Million)
  2. Latin America Hemophilia Management Market By Type, From 2021 to 2026 (USD Million)
  3. Latin America Hemophilia-A Market By Region, From 2021 to 2026 (USD Million)
  4. Latin America Hemophilia-B Market By Region, From 2021 to 2026 (USD Million)
  5. Latin America Hemophilia Management Market By Drug, From 2021 to 2026 (USD Million)
  6. Latin America Octocogalfa Market By Region, From 2021 to 2026 (USD Million)
  7. Latin America Nonacogalfa Market By Region, From 2021 to 2026 (USD Million)
  8. Latin America Desmopressin Market By Region, From 2021 to 2026 (USD Million)
  9. Latin America Other drugs Market By Region, From 2021 to 2026 (USD Million)
  10. Brazil Hemophilia Management Market By Type, From 2021 to 2026 (USD Million)
  11. Brazil Hemophilia Management Market By Drug, From 2021 to 2026 (USD Million)
  12. Argentina Hemophilia Management Market By Type, From 2021 to 2026 (USD Million)
  13. Argentina Hemophilia Management Market By Drug, From 2021 to 2026 (USD Million)
  14. Mexico Hemophilia Management Market By Type, From 2021 to 2026 (USD Million)
  15. Mexico Hemophilia Management Market By Drug, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample